News | December 10, 2023
Briefs: GlaxoSmithKline Pharmaceuticals and Dr. Reddy's Laboratories
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The company is confident of addressing all the observations within the stipulated time
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Subscribe To Our Newsletter & Stay Updated
